Sangamo Soars as Hemophilia Gene Therapy Results Quiet Bears

(Bloomberg) -- Sangamo Therapeutics Inc. soared after encouraging results from an early study of its hemophilia A gene therapy impressed bulls and quieted skeptics.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.